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Abstract
        Background: Sparse information regarding plasma iron concentration in neonatal
             foals and its utility as an inflammatory marker in this population has been published.
          Objectives: To determine the physiologic plasma iron concentration in neonatal foals.
           To assess its utility as an inflammatory marker to predict systemic inflammatory
       response syndrome (SIRS) and as a prognostic marker.
           Animals: Forty-seven ill neonatal foals admitted to a referral equine hospital were
               divided in 2 groups based on the SIRS criteria (24 SIRS and 23 non-SIRS). Two control
             groups of 43 hospital and 135 stud farm healthy neonatal foals were also included.
          Methods: Observational prospective study. Data were summarized by mean and its
         95% confidence interval and absolute frequency and percentage for quantitative
         andqualitative variables. One-way ANOVA, ANCOVA (group and age effects) and
           Dunnett as posthoc analysis were used to compare plasma iron concentration among
groups.
            Results: Neonatal foals with SIRS did not have had any statistically significant differ-
             ent plasma iron concentrations compared to non-SIRS ( = .56) and stud farm controlP
            group ( = .99), 172.8 g/dL (95% CI; 126.0-219.6), 193.1 g/dL (139.1-247.2), andP  
          181.8 g/dL (171.3-192.4), respectively. Plasma iron concentration had a large vari-
            ability in healthy neonatal foals, and was negatively correlated with age in hospital
             controls (rho = 0.387) and sick neonatal foals (rho = 0.598) ( < .001).− − P
             Conclusions and Clinical Importance: Plasma iron was not a useful marker of SIRS in
       neonatal foals and was not associated with outcome.
K E Y W O R D S
         critical care, monitoring, neonatal foals, plasma iron, systemic inflammatory response
syndrome
  1 | I N T R O D U C T I O N
          Sepsis in neonatal foals is associated with higher death rate compared
      with other medical conditions affecting neonatal foals.1  Early detection         Abbreviations: RBC, red blood cell; SIRS, systemic inflammatory response syndrome.
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         of systemic inflammation is essential in order to provide appropriate
treatment. 2      The original systemic inflammatory response syndrome
          (SIRS) criteria in neonatal foals have a significant association with pre-
    diction of sepsis and nonsurvival. 3
          The SIRS term provides a reference for the complex findings that
          resulted from a systemic activation of the innate immune response, regard-
   less of the cause.4     Systemic inflammatory response syndrome describes
         the clinicopathologic effects of the inflammatory response to a variety
       of insults, including bacterial infection, endotoxemia, ischemia, hypoxia,
  trauma, and burns.5         The original SIRS criteria used to describe this clinical
            syndrome in neonatal foals included presence of 2 or more of: (1) hyper-
    o r h y p o - t h e r m i a ( r e c t a l t e m p e r a t u r e > 3 9 . 2   C o r < 3 7 . 2   C ) ; ( 2 ) l e u k o -
          cytos is o r leukopenia (peripheral white blood cell count >12.5 × 10 3/L
   or <4 × 10 3      /L) or > 10% immature (“band”) neutrophils; (3) tachycardia
       (>120 beats/min); and (4) tachypnoea (> 30 breaths/min). 3,5-8  The SIRS
             criteria is much simpler and faster to use than sepsis scores and might serve
             as a more rapid screening tool for sepsis in neonatal foals. A positive result
             to the original SIRS criteria has a sensitivity of 60% and specificity of 69%
         to predict sepsis when compared to other proposed SIRS criteria 3,9,10 and
         could be more useful for predicting nonsurviv al associated with sepsis. 3
Based on the human pediatric literature, an updated SIRS score for foals
           was proposed but it does not provide an improved ability in predicting
sepsis.3,11         SIRS criteria for foals of the aforementioned study required
            the p resen ce of at lea st 3 of : (1) feve r or h ypot h ermi a, (2 ) tac h ycar -
        d i a , ( 3 ) t a c h y p n e a , ( 4 ) l e u k o c y t o s i s , l e u k o p e n i a , > 5 % b a n d n e u t r o -
         p h i l s , ( 5 ) v e n o u s b l o o d l a c t a t e c o n c e n t r a t i o n , o r ( 6 ) v e n o u s b l o o d
          gluco se con centr ation ; at least on e of wh ich ha d to be ab norm al
   temp erat u re or l euko cyte coun t. 9
         In adult hor ses, plasma iron concentrati on acutely decr eases in cases
  with systemic inflammation. 2       Low iron and high fibrin ogen plasma concen-
         trations are both sensitive indicators of systemic inflammati on in horses,
      with sensitivity of 90 and 82%, respectively.12   Rapid development of
         hypoferremia is par ticularly valuable d uring the earliest phas es of i nfection,
         before other components of in nate a nd adapt ive immunity are mobilize d.2
          Red blood cell (RBC) mass in human neonates is highly variable,
            because of changes in both the mass and the composition of RBCs occur-
            ring during the transition from the intra uterine to the extra uterine environ-
ment. 13 Sparse information is published about iron in neonatal foals.14,15
         The objectives of this study were to determine the physiologic
          values of plasma iron concentrations in neonatal foals (<14 days old),
            and to assess its utility as both an early inflammatory marker to pre-
         dict SIRS and a prognostic marker in sick neonatal foals.
    2 | M A T E R I A L S A N D M E T H O D S
  2.1 Animals|
            Neonatal foals (<14 days old) referred to the Equine Unit of the Fun-
         dació Hospital Clínic Veterinari of the Universitat Autònoma de Barce-
           lona from January 2005 to December 2011 were included if a blood
        sample was taken before any treatment was administered. Forty-seven
             ill neonatal foals were divided in 2 groups: SIRS (n = 24) and non-SIRS
               (n = 23). The SIRS group was defined as meeting 2 or more of: (1) hyper-
    or hypo-thermia (rectal temperature >39.2C or <37.2   C), (2) leukocy-
          tosis or leukopenia (peripheral white blood cell count >12.5 10× 3/ L
   or < 4 × 103        / L) or >10% immature ( band “ ”) n eutr ophi ls, ( 3) t achyc ardi a
      (>120 beats/min), and (4) tachypnea (>30 breaths/min).3,5-8
           Foals that did not meet the SIRS criteria were classified as non-
          SIRS. The hospital control group (n = 43) included healthy neonatal
           foals admitted to the same referral equine hospital from 2005 to 2011
         that had a normal physical examination and were accompanying their
         sick dams. Another control group was added, including 135 healthy
          neonatal foals from a nearby endurance stud farm over the 2017
          foaling season. These were 24-48 hour-old foals with history of normal
         foaling, normal physical exam at birth and serum immunoglobulin G
        (IgG) concentration above 800 mg/dL within 24-48 hours postpartum.
          Sick foal s ( ie, SIRS and no S IRS grou ps) we re also cla ssif ied
         acco rding to ou tcom e int o sur vivo r s (n = 29) an d non surv ivor s
          (n = 1 8). Th e non survi vor grou p incl ude d both case s of natu ral
            deat hs (n = 4) and euth aniz ed be cause of p oor prog nosis (n = 14) .
          None of the foal s in clud ed i n the non survi vor gro up wa s eu than ized
   becau se of fin an cial res trai nts.
      2.2 Blood sampl ing and measured variables|
          Blood samples from ill neonatal foals were collected at admission in
      ethylenediaminetetraacetic acid (EDTA) and lithium heparin tubes.
        Similarly, blood samples from healthy hospital neonatal foals (hospital
        control group) were collected at different times during hospitalization,
          usually within the first 48 hours of admission. Finally, blood samples
           from stud farm control group were collected from 24 to 48 hours
 after birth.
          Blood collected in EDTA from sick foals was used to determine
       manual hematocrit, total protein by refractometry, manual fibrinogen
   by heat precipitation method,16      and also to perform Diff-Quick stained
         blood smears and complete cell blood count using automated hematol-
         ogy analyzers (Advia 120, Siemens Health Care Diagnostics SL, Barce-
        lona, Spain; LaserCyte, Idexx laboratories, Inc, Netherlands). In the
         hospital control group, in addition to a normal physical examination,
       hematocrit, total protein and fibrinogen concentrations were deter-
            mined to support that foals were healthy to be included in this group
            (data not shown). In the stud farm control group, serum IgG and plasma
         iron concentration were the only measured variables. Serum IgG was
        determined using a portable quantitative analyzer (DVM Rapid TestTM
           II - Multi-Test Analyzer Tests, Florida) for the stud farm control group
    and semiquantitative turbidimetric test (ZnSO4    test) for the hospital
         control group and sick group. Plasma iron concentration was measured
        from lithium heparin plasma samples with an automated chemistry
       a n a l y z e r ( O l y m p u s A U 4 0 0 , H a m b u r g , G e r m a n y ) u s i n g a c o n v e n t i o n a l
      enzym atic colo rime tric as say ( Olymp us Sys tem R ea gen t, Beck man
      Coul t er, Galwa y, I rela nd) b y the TPT Z [2, 4,6- Tri-( 2-p irid il)-5 -tri acin a]
 as chr omog en.
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   2.3 Data analysis|
           The main objective of this study was to establish the usefulness of
         iron concentration for diagnosis and prognosis in neonatal foals and
           obtain an estimate of limits of abnormality (ie, reference range) in neo-
         natal foals. These limits were estimated by calculation of individual
            95% confidence intervals (95% CI) (ie, from the SD as a measure of
        variability), and absolute range (minimum and maximum) for plasma
         iron concentration for each group, defined as sick, hospital control
          and stud farm control groups. One-way ANOVA and Dunnett as post-
       hoc analysis of group comparisons detected differences between
          groups. To evaluate the effect of age on plasma iron concentration,
          ANCOVA analysis of group as independent factor and age as covari-
         ate was performed. Additionally, using test for independent groups,t
       differences between SIRS, non-SIRS, and outcome were explored
            from 95% CI of mean (ie, using SE as measure of variability). Cutoffs
             of less than 59, 79, and 105 g/dL were tested in order to evaluate
           the utility of external limits of plasma iron concentration and a Fisher's
         exact test was performed. Other variables were described by mean
          and their 95% CI and absolute frequency and percentage for quantita-
        tive and qualitative variables, respectively. All statistical analyses were
         performed using a statistical software package (SPSS version 25, SPSS
          Inc, Chicago, Illinois) and all analyses were performed with a 2-sided
    Type I error of 5%.
  3 | R E S U L T S
             A total of 225 neonatal foals (<14 days old) were included in the study.
           Forty-seven out of 225 were sick neonatal foals with mean age of
           3.0 days (95% CI; 2.2-3.9 days). Sick neonatal foals were divided into
             SIRS group (n = 24), mean age 3.5 days (95% CI; 2.2-4.8 days), and
            non-SIRS group (n = 23), mean age 2.6 days (95% CI; 1.5-3.7 days).
          Forty-three were healthy foals admitted to the hospital, with mean age
            4.5 days (95% CI; 3.4-5.6 days) and the 135 healthy neonatal foals left
             were from a stud farm with mean age 1.5 days (95% CI; 1.5-1.5 days).
           The 95% CI limits of plasma iron concentration of the sick group
              were similar to the stud control group ( = .99) (Table 1; Figure 1). TheP
          hospital control group had significantly lower 95% CI limits of plasma
        iron concentrations and lower mean plasma iron concentration than
            sick group ( = .002) (Table 1; Figure 1). With ANCOVA analysis, thereP
         was no significant difference between the hospital control and sick
               foals ( = .06) but age effect was present ( = .001; Figure 2). A nega-P P
          tive moderate correlation with age was seen in the hospital control
             group (rho = 0.387) and in the sick group (rho = 0.598), so the− −
         higher the age the lower the iron concentration. Greater variability
          and higher iron plasma concentrations were specially seen in the first
     3 days of life (Figure 2).
          Both individual 95% CI and absolute range of plasma iron concen-
          tration of SIRS group overlapped with the non-SIRS group (Table 2;
         Figure 3). Plasma iron concentration of non-SIRS group (193.10 g/dL)
         was not statistically significant different to SIRS group (172.77 g/ dL)
    (P = . 56 ; F igur e 3 ).
     T A B L E 1 Individual 95% confidence intervals
      Stud farm contro ls Hospital controls Sick foals
          Iron ( g/dL) Ind (95% CI) (58.8; 305) (0.0; 303) (0.0; 420)
   Range 35.0-339.1 13.9-394.8 20.7-474.9
   Mean (95% CI) 181.8 a   (171.3; 192.4) 126.1 b   (99.2; 153.1) 183.2 a  (148.5; 217.8)
   N 135 43 47
     Age (days) Mean (95% CI) 1.5c   (1.5; 1.5) 4.5 c   (3.4; 5.6) 3.0 c  (2.2; 3.9)
   Range 1.5-1.5 1-13 1-11
   N 135 43 47
                      Note: Data presented as individual 95% confidence interval (Ind (95% CI)); range, (minimum and maximum); mean (95% CI), 95% confidence intervals of the
    mean; N, number of foals.
a         Indicates no significant difference between groups ( > .5).P
b        Indicates significant difference between groups ( < .05).P
c            Indicates significant difference betwee n groups with the ANCOV A model ( < .001).P
        F I G U R E 1 Scatterplot of plasma iron concentrations ( g/dL) in
         stud farm controls (open circles), hospital controls (solid circles), and
        sick neonatal foals (solid triangles). Horizontal line indicates mean
     plasma iron concentration for each group
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         Sick neonatal foals were divided according to outcome into survival
             group (n = 29) and nonsurvival group (n = 18) (Figure 3). Survival group
          showed mean plasma iron concentration of 184.58 g/dL with 95% CI
       limits of concentration (136.71-232.46 g/dL) and nonsurvival group
        180.84 g/dL with 95% CI limits of concentration (127.48-234.20).
        Plasma iron concentration was not statistically associated with outcome
 (P = . 9 2).
          External cutoff values (less than 59, 79, and 105 g/dL) were
        applied for plasma iron concentration with no statistically significant
    differences between those (Table 2).
  4 | D I S C U S S I O N
            The main findings of this study were: (1) the large variability of plasma
          iron concentration in healthy neonatal foals, (2) the lack of statistically
         significant differences in plasma iron concentration in sick and SIRS
           affected foals relative to those in healthy foals, and (3) a negative
                    F I G U R E 2 Scatterplot of the relationship of plasma iron concentrations ( g/dL) and age (days) in healthy [stud farm controls (open circles)
          and hospital controls (solid circles)] and sick neonatal foals (solid triangles)
    T A B L E 2 Plasma iron concentration
      in sick neonatal foals with SIRS versus
non-SIRS
  Non-SIRS SIRS -valueP
 N 24 23
          Iron ( g/dL) Ind (95% CI) 193 (0.0; 458) 173 (0.0; 397)
  Range 20.7 474.9 37.5-369.6–
         Mean (95% CI) 193.1 (139.1; 247.2) 172.8 (126.0 ; 219.6) .56
         Iron < 59 g/dL No 20 (87.0%) 1.0 20 (83.3%)
    Yes 4 (16.7%) 3 (13.0%)
         Iron < 79 g/dL No 19 (82.6%) 1.0 19 (79.2%)
    Yes 5 (20.8%) 4 (17.4%)
         Iron < 105 g/dL No 16 (69.6%) .75 18 (75.0%)
    Yes 6 (25.0%) 7 (30.4%)
                      Note: Data presented as individual 95% confidence interval (Ind 95% CI); range, (minimum and maximum); Mean (95% CI), 95% confidence intervals of the
    mean; N, number of foals.
        F I G U R E 3 Scatterplot of plasma iron concentrations ( g/dL) in
        sick neonatal foals: SIRS survivors (upright solid triangles), SIRS
      nonsurvivors (upside down solid triangles), non-SIRS survivors
       (upright open triangles) and non-SIRS nonsurvivors (upside down
       open triangles). Horizontal line indicates mean plasma iron
   concentration for each group
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         correlation between plasma iron concentration and age for the first
   2 weeks of life.
            Neonatal foals in the stud control group (n = 135), only had a
           24 hours range of age dispersion between all individuals, and their mean
          plasma iron concentration was 181.84 g/dL, which is similar to the
          estimated average concentrations in neonatal foals of 1 day of age 14 ;
         but presented a wider distribution (58.8-305 g/dL) compared to previ-
        ously published plasma iron concentration in adults (105-277 g/dL). 2,12
          In healthy foals at birth, plasma iron and ferritin concentrations are
            lower than in adult horses, followed by a rapid increase in the first
         24 h ours as a result of absorption of colostrum iron. 14  Colostrum and
             milk are the major source of iron for neonatal foals with an average iron
          concentration of 0 .79 mg/L i n col ostrum and 0.34 mg/L in mi lk. 17 Dur-
           ing the first 3 weeks of life, concentrations fall below concentrations of
        adults, reaching a nadir at 3 weeks of age. 18    The same r apid changes
        occur after delivery in human newborns, when hemoglobin breakdown
          leads to storage of the iron by-products for future erythrocyte produc-
         tion. Within the first week after delivery, hemoglobin and hematocrit
            values are higher and begin to drop in response to the higher ambient
   oxygen concentration ex utero. 13 Bas ed o n pre vi ous s tu die s of i ron
  metabolism in foals 16      where plasma iron concentration and several
          hematologic values changed rapidly during the first days of life in
         healthy foals we expected fluctuations depending on foals’ age; how-
            ever, it was unexpected to observe a large variability of plasma iron con-
            centrations in neonatal foals of a given age (ie, 24-48 h). In addition,
         significant differences between healthy and SIRS foals were expected in
          this study but were not observed. Perhaps, grouping foals according to
              age (ie, 1-3 days, 3-7 days, and <14 days) would have helped us to bet-
    ter assess plasma iron dynamics.
          In the studied population of neonatal foals, there was no significant
        difference in mean plasma iron concentrations between healthy foals
           and sick foals ( = .99). In equine medicine, previous reports suggestP
           that plasma iron concentrations in adult horses are an acute and sensi-
    tive indicator of systemic inflammation. 2,12     In adult horses plasma iron
         concentration is considered decreased when values fall below the ref-
   erence interval (105-277 g/dL). 2      We expected to find lower iron
          plasma concentrations in sick foals compared to healthy foals, as occurs
          in the equine adult population because of the iron withholding mecha-
         nism. In the setting of infectious, inflammatory, and neoplastic diseases,
           a primitive defense mechanism of the organism is to withhold iron from
microorganisms. 20       The iron withholding defense system includes con-
       stitutive iron-binding components such as transferrin, lactoferrin, and
          ovotransferrin, as well as the suppression of iron efflux from macro-
         phages, reduction in plasmatic iron, and increased synthesis of ferritin
       by macrophages to accommodate iron from phagocytised lactoferrin
iron. 21          At baseline and in response to nutritional iron deficiency, infec-
       tion, bleeding and pregnancy, hepcidin regulates iron metabolism. 22
        Hepcidin is potently induced by inflammation, predominantly by the
          cytokine IL-6, and has shown to be essential for innate immunity
  to gram-negative bacteria.22      This hormone controls iron flows into
         plasma through inhibition of the only known mammalian cellular iron
 exporter ferroportin.23      Hepcidin is feedback-regulated by iron status
       and strongly modulated by inflammation and erythropoietic demand.23
         Studies of plasma iron concentrations in neonatal foals with SIRS
           are sparse or nonexistent. The SIRS criteria have been defined in vet er-
    i n a r y m e d i c i n e b y d i f f e r e n t a u t h o r s . 3 , 7 , 2 4 , 2 5   The stan dar d v ar iab les
          reported to define SIRS have been: (1) temperature, (2) heart rate
           (HR), (3) respiratory rate (RR), and (4) white blood cell counts (WBC)
       or presence of immature neutrophils. Comparison between various
           studies of SIRS in neonatal foals could be hampered given the differ-
           ences in criteria and cutoff values relative to the definition of criteria
          of SIRS in neonatal foals. Some authors suggest different cutoff values
            for HR, RR, WBC in neonatal foals as well as including blood glucose
  and lactate concentrations3,9,10,26      and others, include a fifth criteria;
       evidence of sepsis, cerebral hypoxia, ischemia, or trauma. 8  The true
            clinical utility of the SIRS criteria in neonatal foals remains to be deter-
mined.3            In the present study a decision was made to use the original
         SIRS criteria rather than the neonatal SIRS criteria including glucose
        and lactate concentrations, because a higher sensitivity (60% versus
      42%) to predict sepsis has been demonstrated.3    Although one of the
           weak points of the original SIRS criteria is that foals presenting only
          tachycardia and tachypnea could be misclassified in the SIRS group, in
        our population considering the updated neonatal SIRS criteria afore-
            mentioned, on ly 3 of 24 SIRS foals would b e in t his si tuation. Plasma
         iron concentrations for these neonatal foals were 345, 369.6, and
         359.9 g/dL, respectively. Using both SIRS criteria (original and updated)
            14 of 47 sick neonatal foals would be classified in the SIRS group.
         Although SIRS criteria are much simpler and faster screening tool
          for sepsis detection than sepsis scores, the clinician must be cognizant
              of the fact that SIRS can be caused by a number of causes other than
       infection such as trauma, burns, pancreatitis, ischemia, hemorrhage,
 and anaphylaxis. 5,7        In the present population of foals classified with
           the original SIRS criteria, no differences were seen in plasma iron con-
         centration between SIRS and non-SIRS sick foals. The expected find-
         ing would have been higher plasma iron concentrations in hospital
        controls and significantly lower plasma iron concentrations in neonatal
            foals with SIRS. Data on the incidence of SIRS and the usefulness of
       biomarkers of SIRS in veterinary medicine are scarce. 27  Other markers
       of systemic inflammation currently validated in equine neonatology
     are plasma fibrinogen, serum amyloid A 28,29   and C-reactive protein
concentrations.30
        In the study herein reported, surprisingly, different plasma iron
       concentrations resulted from each healthy control groups (hospital-
        ized controls: 126.1 [99.2-153.1] g/dL and stud controls: 181.8
          [171.3-192.4] g/dL, mean and [95% CI of the mean], respectively). It
          could be reasonable to think that sick dams can be hypogalactic,17
           and as explained before, colostrum and milk are the major source of
        iron for newborns. Perhaps measuring plasma and colostrum/milk iron
         concentration of the mares and the amount of colostrum ingested
         would have been useful in explaining the differences between the
          control populations. On the other hand, these results could also be
            explained by the effect of the age ( < .001). Age differences betweenP
          the stud control and healthy hospitalized foals (1.5 versus 4.5 days,
         respectively) could at least partly explain the differences observed in
          plasma iron concentrations (Figure 2). To rule out the age effect
         in future studies, we suggest classifying foals according to age
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            (ie, 1-3 days, 3-7 days, and <14 days), in order to differentiate plasma
         iron concentrations in SIRS and non-SIRS neonates as some other
       authors have done measuring age-dependent plasma biochemical vari-
   ables in neonatal foals. 31
          Another of the li mitations of th is study could be the abse nce
        of info rmation regar ding ir on met ab olism in th e ani mals incl uded,
        because, except for plasma iron co ncentrati on, no other variable s
         related to iron meta bolism were analyze d. Ir on met abolism in equine
          medicine can be direct ly evalua ted by meas uring t he amount of iron
          in the blo od, in cluding: plasma iron co ncentration , th e cap acit y of the
          blood to transp ort i ron b y mea suring transf errin or total iron bind ing
         capacity ( TIBC) and the am ount of iron sto rage measuri ng ferrit in. 1 8
            Another limitati on of th is study co uld be the lack of a full hema tology
          data from the stud cont rol gro up. All samples were t aken from
         healthy foals based on: normal foali ng, norm al phy sical exam, and
       serum i mmunoglobul i n G con centration above 800 mg /dL withi n
        24-48 hours post partum. Despi te this limi tation, we con sidered tha t
         a large hom ogeneous hea lthy group , with a dai ly close ve terinary
         follow-u p was still of a gre at value fo r t he study.
    5 | C O N C L U S I O N S A N D C L I N I C A L
R E L E V A N C E
         In summary, plasma iron concentration has a negative moderate cor-
           relation with age in neonatal foals. Unlike what is reported in adult
         horses plasma iron concentration is not a useful early inflammatory’
            marker to predict SIRS in sick neonatal foals. Based on results of this
          study plasma iron concentration in healthy neonatal foals has a larger
        variability compared to adults. Finally, plasma iron concentration is
       not a useful prognostic marker in this population.
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